Guopan Yu
9PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|May 28, 2025
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in first complete remission: a randomized controlled trial.Yu Zhang, Zinan Feng, Jing Du
|Feb 12, 2025
Venetoclax added to CLAG regimen might improve the outcome of patients with relapsed/refractory acute myeloid leukemia.Yu Zhang, Zhao Yin, Zurong Yao
|Nov 12, 2024
Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study.Guopan Yu, Yu Zhang, Sijian Yu
|Sep 05, 2024
Homoharringtonine sensitized resistant acute myeloid leukemia cells to venetoclax-induced apoptosis.Zhao Yin, Ya Gao, Xiaoyin Bu
|Jul 22, 2024
Trafficking circuit of CD8+ T cells between the intestine and bone marrow governs antitumour immunity.Rong-Yi Shi, Neng Zhou, Li Xuan
Pageof 2
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)